Seres Therapeutics

Biotechnology Research • Cambridge, Massachusetts, United States • 101-200 Employees

Company overview

Headquarters	101 Cambridgepark Dr, Cambridge, Massachusetts 02140, US
Phone number	+16179459626
Website	serestherapeutics.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Therapeutics, Microbiome
Founded	2010
Employees	101-200
Socials

Key Contact at Seres Therapeutics

Eric Shaff

President, Chief Executive Officer

Mobile @serestherapeutics.com

Seres Therapeutics Email Formats

Seres Therapeutics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@serestherapeutics.com), used 75.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@serestherapeutics.com	75.7%
{first name}{last name}	johndoe@serestherapeutics.com	16.5%
{last name}{last name}	doedoe@serestherapeutics.com	7.8%

About Seres Therapeutics

Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWST™, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in medically compromised patients. We are also conducting research to inform further development of microbiome therapeutics for ulcerative colitis. For more information, please visit http://www.serestherapeutics.com/ .

Seres Therapeutics revenue & valuation

Annual revenue	$126,400,000
Revenue per employee	$766,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$404,300,000
Total funding	$110,000,000

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Entry

Director

Senior

Employees by Department

Seres Therapeutics has 77 employees across 13 departments.

Departments

Number of employees

Funding Data

Explore Seres Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-05-27	16	$110,000,000

Funding Insights

$110,000,000

Total funding amount

$110,000,000

Most recent funding amount

Number of funding rounds

Seres Therapeutics Tech Stack

Discover the technologies and tools that power Seres Therapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

WP Rocket

Caching

Swiper

JavaScript libraries

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

Frequently asked questions

Seres Therapeutics is located in Cambridge, Massachusetts, US.

You can reach Seres Therapeutics at +16179459626.

Seres Therapeutics was founded in 2010, making it 16 years old. The company has established itself as a significant player in its industry over this time.

Seres Therapeutics has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Seres Therapeutics has raised a total of $110,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Seres Therapeutics

Eric Shaff

President, Chief Executive Officer

Mobile @serestherapeutics.com

4.8

40,000 users